MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Institutional Ownership Changes & 13F Activity
MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include T. Rowe Price Investment Management, Inc., Weiss Asset Management Lp, Cormorant Asset Management, Lp, Logos Global Management Lp, and Goldman Sachs Group Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -9,381 | -7.9% | 109,580 | $2.13M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +649,165 | +49.0% | 1,972,893 | $38.41M | Q2 2026 | Sep 02, 2026 |
| Cornerstone Financial Management Llc | Buy | +29 | +103.6% | 57 | $1.11K | Q2 2026 | Aug 28, 2026 |
| Optimize Financial Inc | Sell | -84 | -0.3% | 24,335 | $473.80K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +8,543 | +29.2% | 37,839 | $736.73K | Q2 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Buy | +13,202 | — | 13,202 | $257.04K | Q2 2026 | Aug 19, 2026 |
| Stonepine Capital Management, Llc | Buy | +50,000 | — | 50,000 | $973.50K | Q2 2026 | Aug 17, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +4,280,624 | — | 4,280,624 | $83.34M | Q2 2026 | Aug 14, 2026 |
| Weiss Asset Management Lp | Buy | +2,581,813 | — | 2,581,813 | $50.27M | Q2 2026 | Aug 14, 2026 |
| Cormorant Asset Management, Lp | Sell | -1,275,000 | -28.5% | 3,205,433 | $62.41M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +1,175,000 | +78.3% | 2,675,000 | $52.08M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -1,000,799 | -88.5% | 129,434 | $2.52M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +974,846 | +40.8% | 3,365,507 | $65.53M | Q2 2026 | Aug 14, 2026 |
| Trails Edge Capital Partners, Lp | Buy | +750,000 | — | 750,000 | $14.60M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +593,037 | +52.8% | 1,715,349 | $33.40M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +590,162 | +9.2% | 6,999,025 | $136.27M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +453,325 | +1056.3% | 496,242 | $9.66M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Sell | -430,137 | -94.1% | 27,000 | $525.69K | Q2 2026 | Aug 14, 2026 |
| Vivo Capital, Llc | Buy | +400,000 | +40.0% | 1,400,000 | $27.26M | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +399,761 | +88.1% | 853,386 | $16.62M | Q2 2026 | Aug 14, 2026 |
| Great Point Partners Llc | Buy | +355,813 | +71.2% | 855,813 | $16.66M | Q2 2026 | Aug 14, 2026 |
| Holocene Advisors, Lp | Sell | -350,000 | -58.3% | 250,000 | $4.87M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +312,699 | +677.1% | 358,884 | $6.99M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -253,334 | -19.6% | 1,041,527 | $20.28M | Q2 2026 | Aug 14, 2026 |
| Burkehill Global Management, Lp | Buy | +250,000 | — | 250,000 | $4.87M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Sell | -248,443 | -60.6% | 161,557 | $3.15M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Sell | -209,786 | -15.3% | 1,158,732 | $22.56M | Q2 2026 | Aug 14, 2026 |
| Verition Fund Management Llc | Buy | +207,102 | — | 207,102 | $4.03M | Q2 2026 | Aug 14, 2026 |
| Mpm Bioimpact Llc | Sell | -204,115 | -11.3% | 1,606,967 | $31.29M | Q2 2026 | Aug 14, 2026 |
| Voleon Capital Management Lp | Sell | -199,112 | -53.4% | 173,909 | $3.39M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about MLTX activity
Which institutional owners are buying MLTX?
Institutional owners buying MLTX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in MLTX activity?
"Buy" means an investor increased their reported position in MLTX compared to the prior reporting period. This reflects growing exposure to MOONLAKE IMMUNOTHERAPEUTICS (MLTX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in MLTX increasing?
Institutional interest in MLTX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related MLTX Institutional Insights
- MLTX Overview
- MLTX 13F Institutional Holders
- MLTX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- MLTX Insider Trading & SEC Form 4 Activity
- MLTX Articles
- Top Institutional Investor Stock Rankings